Aromatherapeutic Honey Bandage

20230330298 · 2023-10-19

    Inventors

    Cpc classification

    International classification

    Abstract

    The present invention relates to an improved aromatherapeutic, moist, sterile, medium to large wound bandage that is at least equivocal to a manuka honey bandage in antimicrobial effectiveness with improved wound healing and effect on mood.

    Claims

    1. A moist, sterile, sporicidal, aromatherapeutic wound or burn bandage containing non-manuka honey and a fragrance that has a therapeutic effect of improving mood.

    2. A bandage in claim #1 that contains vanillin.

    3. A bandage in claim #1 that contains limonene.

    4. A bandage in claim #1 that contains linalyl acetate.

    5. A bandage in claim #1 that contains eucalyptol.

    6. A bandage in claim #1 that contains piperonal.

    7. A bandage in claim #1 that contains citral.

    8. A bandage in claim #1 that contains geraniol.

    9. A bandage in claim #1 that contains benzaldehyde.

    10. A bandage in claim #1 that contains orange blossom honey.

    11. A bandage in claim #1 that has a picture or drawing of at least one orange, orange blossom, or lavender flower on the bandage or packaging.

    12. A moist, non-manuka wound honey bandage that is stored or sold in the form of a gauze bandage with a surface area of at least 30 square inches.

    13. A bandage in claim #12 that is stored in a roll.

    14. A preservative containing vanillin, limonene, linalool, linalyl acetate, and a monoglyceride.

    15. A wound honey bandage with the preservative in claim #14.

    Description

    DETAILED DESCRIPTION

    [0015] Definitions: Moist bandage refers to a bandage containing 4% or more water by weight.

    [0016] The following description of technology is merely exemplary in nature of the subject matter, manufacture and use of one or more inventions, and is not intended to limit the scope, application, or uses of any specific invention claimed in this application or in such other applications as may be filed claiming priority to this application, or patents issuing therefrom. Regarding methods disclosed, the order of the steps presented is exemplary in nature, and thus, the order of the steps can be different in various embodiments, including where certain steps can be simultaneously performed. “A” and “an” as used herein indicate “at least one” of the item is present; a plurality of such items may be present, when possible. Except where otherwise expressly indicated, all numerical quantities in this description are to be understood as modified by the word “about” and all geometric and spatial descriptors are to be understood as modified by the word “substantially” in describing the broadest scope of the technology. “About” when applied to numerical values indicates that the calculation or the measurement allows some slight imprecision in the value (with some approach to exactness in the value; approximately or reasonably close to the value; nearly). If, for some reason, the imprecision provided by “about” and/or “substantially” is not otherwise understood in the art with this ordinary meaning, then “about” and/or “substantially” as used herein indicates at least variations that may arise from ordinary methods of measuring or using such parameters.

    [0017] The present disclosure relates to a honey bandage that is equivalent to manuka honey bandages on the market but is larger, heals wounds faster through appropriate moisture levels, and improves mood through aromatherapy.

    [0018] One example of several potential medical products that does not limit this patent application, is sterile orange blossom honey bandage with 1.5% vanillin, 0.4% limonene, 0.2% linalyl acetate, 0.2% linalool, and 0.15% monolaurin. This product may be soaked into a 4.5 inch×4.1 yard gauze roll and stored in a resealable bag.

    [0019] Another example that does not limit this patent application, is sterile orange blossom honey gauze packing with 0.75% vanillin, 0.2% limonene, 0.1% linalyl acetate, 0.1% linalool, and 0.075% monolaurin. This product may be soaked into a 0.5 inch×5 yard gauze packing and stored in a plastic bottle with a cap.

    [0020] A variation, that does not limit this patent, is a sterile medical honey abdominal pad with 1.5% benzaldehyde, 0.4% lemongrass essential oil, and 0.15% glycerol monostearate on a 12 inch by 16 inch abdominal pad that can be used in the hospital.

    [0021] It is desirable for the supplement to have a low water activity level. Honey naturally has a low water activity level containing approximately 17% water. Other additional humectants may include nitric acid, dextrose, fructose, glycerol, glycine, glucose, malic acid, salt, sorbitol, sucrose, and tartaric acid. A skilled artisan may select any suitable humectant, as desired. For example, the supplement can have a water activity level of 0.86.

    [0022] It is also desirable for a product to have a low pH as this inhibits microbes. Honey typically has a pH between 3.5 and 5.5. Acids lower the pH. Some acids, such as formic acid, acetic acid, oxalic acid, nitric acid, lactic acid, succinic acid, tartaric acid, citric acid, propionic acid, sulfhuric acid, benzoic acid, sorbic acid, sulphamic acid, phosphoric acid, mandelic acid, and adipic acid have synergistic antimicrobial effects with hydrogen peroxide against bacteria. Hydrogen peroxide is naturally found in non-mauka type honeys.

    [0023] Example embodiments are provided so that this disclosure will be thorough and will fully convey the scope to those who are skilled in the art. Numerous specific details are set forth such as examples of specific components, devices, and methods, to provide a thorough understanding of embodiments of the present disclosure. It will be apparent to those skilled in the art that specific details need not be employed, that example embodiments may be embodied in many different forms, and that neither should be construed to limit the scope of the disclosure. In some example embodiments, well-known processes, well-known device structures, and well-known technologies are not described in detail. Equivalent changes, modifications and variations of some embodiments, materials, compositions and methods can be made within the scope of the present technology, with substantially similar results.